Presented at the ASCP Annual Meeting May 29-31,2020 Virtual Conference

The VRFCAT is currently used in industry trials across diverse CNS indications including major depression and Parkinson’s disease. In order to meet a growing need for culturally appropriate performance-based assessments of functioning in global clinical trials, we recently completed translation and cultural adaptation of the VRFCAT for use in Italian, Polish, Russian, German, and Spanish for the US.This poster describes the methods used for professional translation and cultural adaptation of the VRFCAT, and results from the cognitive debriefing and pilot testing conducted at in-country investigational sites.

Download Poster